AQP-1180

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAQP-1180
Drug Alias NameAQP-1180
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNuclear factor erythroid 2-related factor 2 modulatorsNuclear factor NF-kappa-B complex modulators
TargetsNuclear factor erythroid 2-related factor 2Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAquapharm Biodiscovery Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAquapharm Biodiscovery Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A